thiamine has been researched along with Tauopathies in 1 studies
thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tapias, V | 1 |
| Jainuddin, S | 1 |
| Ahuja, M | 1 |
| Stack, C | 1 |
| Elipenahli, C | 1 |
| Vignisse, J | 1 |
| Gerges, M | 1 |
| Starkova, N | 1 |
| Xu, H | 1 |
| Starkov, AA | 1 |
| Bettendorff, L | 1 |
| Hushpulian, DM | 1 |
| Smirnova, NA | 1 |
| Gazaryan, IG | 1 |
| Kaidery, NA | 1 |
| Wakade, S | 1 |
| Calingasan, NY | 1 |
| Thomas, B | 1 |
| Gibson, GE | 1 |
| Dumont, M | 1 |
| Beal, MF | 1 |
1 other study available for thiamine and Tauopathies
| Article | Year |
|---|---|
Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.
Topics: Amyloid beta-Peptides; Animals; Antioxidant Response Elements; Brain; Disease Models, Animal; Humans | 2018 |